跳至主要内容
临床试验/ACTRN12613000590763
ACTRN12613000590763已完成不适用

To explore safety, feasibility and acceptability of mobile teledermoscopy for Queensland residents 50-64 years at high risk for melanoma.

Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI)0 个研究点目标入组 50 人开始时间: 2013年5月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
50 Years 至 64 Years(—)
性别
All

入选标准

  • Inclusion criteria include: Male and female between 50-64 years of age in Queensland. Previous melanoma or skin cancer diagnosis, fair skin or high number of moles. In addition, stratified sampling will ascertain that 50% of participants will have a history of checking their own skin, whilst the other 50% will have no record of SSE. All participants must be able to speak English to give informed consent. Participants must have access to a smartphone.

排除标准

  • People who do not have access to an iPhone, People who have cognitive impairment that prevents them from providing informed consent, People who do not speak English for informed consent, those living outside of Queensland and not available for a visit to QUT for a skin exam.

研究者

发起方
Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI)

相似试验